{
  "created_at": "Thu Jan 28 18:15:49 +0000 2021",
  "id_str": "1354754875251372033",
  "full_text": "Europe's AstraZeneca vaccine deliveries will be scaled back by two-thirds or more in the first quarter of the year. This comes on top of Pfizer-BioNTech also pushing back promised deliveries by a few weeks https://t.co/6WIGd5pkJa",
  "display_text_range": [
    0,
    229
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/6WIGd5pkJa",
        "expanded_url": "https://econ.st/2YjZPnV",
        "display_url": "econ.st/2YjZPnV",
        "indices": [
          206,
          229
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 40,
  "favorite_count": 71,
  "possibly_sensitive": false,
  "original_created_at": "Thu Jan 28 11:35:07 +0000 2021",
  "localize": [
    {
      "locale": "zh",
      "full_text": "欧洲的阿斯利康疫苗交付量将在今年第一季度缩减三分之二或更多。此前，辉瑞生物技术公司也将承诺的交付时间推迟了几周https://t.co/6WIGd5pkJa。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "歐洲的阿斯利康疫苗交付量將在今年第一季度縮減三分之二或更多。此前，輝瑞生物技術公司也將承諾的交付時間推遲了幾周https://t.co/6WIGd5pkJa。"
    }
  ]
}